Journal of cardiothoracic surgery · 2026
Scedosporium apiospermum endocarditis in an immunocompetent patient: a case report and literature review.
Клинический случайСтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Jingjing, Sun Wenqing, Li Lei, Liu Dandan, Zhang Qingbin
Аннотация
BACKGROUND: Scedosporium apiospermum endocarditis is an exceptionally rare condition, predominantly observed in immunocompromised individuals or those undergoing invasive interventions such as central venous catheterization or prosthetic cardiac valve implantation. Its occurrence in immunocompetent adults with native valves is even more uncommon. This case represents the first documented instance in China. This study presents the first documented case of Scedosporium apiospermum endocarditis in an immunocompetent male patient in China.
CONCLUSION: S. apiospermum endocarditis carries a grave prognosis. Among 18 reviewed articals, 19 patients succumbed to the infection, 7 of whom were diagnosed postmortem, precluding therapeutic intervention. Only one survivor was reported following implantable cardioverter-defibrillator (ICD) extraction and voriconazole treatment. These findings underscore the insidious onset, diagnostic challenges, frequent therapeutic delays, and extremely high mortality associated with this infection.
CONCLUSION: S. apiospermum endocarditis carries a grave prognosis. Among 18 reviewed articals, 19 patients succumbed to the infection, 7 of whom were diagnosed postmortem, precluding therapeutic intervention. Only one survivor was reported following implantable cardioverter-defibrillator (ICD) extraction and voriconazole treatment. These findings underscore the insidious onset, diagnostic challenges, frequent therapeutic delays, and extremely high mortality associated with this infection.